From (Epi)Genetics-To-Precision (E2p): Non-Protein Coding Rnas (Ncrnas) a Step-Toward Precision Medicine
暫譯: 從（表）遺傳學到精準醫療（E2p）：非蛋白質編碼RNA（Ncrnas）邁向精準醫療的一步

Professor Nadia M. Hamdy is a renowned researcher with significant contributions to the scientific community since 2004. She has over 120 publications, 5 book chapters, and a Scopus h-index of 43. She has supervised 50 masters' and PhD students and has received numerous awards, including the life-time acheivement award 2025, Obada International Award for Distinguished Researchers 2025, ASU Appreciation Award in Technological Sciences 2024, ASRT-Egypt State Award Dr. Shawky el Hadad Award in cancer 2023, and the International "Wendy Harvan" Top Honorary Award in February 2023, and several international Honorary Awards in 2025 and 2021. Her research interests include pharmaceutical clinical biochemistry, molecular biology, genetic studies, biomarkers, immuno-oncology, biotechnology, and nano-biotechnology. She focuses on understanding genetic and epigenetic mechanisms of cancers and diseases, developing biomarkers for disease prognosis, and exploring innovative therapeutic approaches. She is also a member of the editorial board of 9 Q1 & Q2 Scopus journals and a reviewer for international and regional grants, awards, and scientific journals. Professor Ahmed S. Sultan is a distinguished Professor of Stem Cell and Molecular Oncology at Georgetown University Medical Center. He received his MD/PhD from Osaka University School of Medicine in 1999 and an M.P.H. from Georgetown University in 2005. Dr. Sultan's research interests include clinical biochemistry, molecular biology, gene therapy for breast and liver cancer, and the role of stem cells in cancer models. His innovative research focuses on discovering new methods and treatment strategies for metastatic cancers, isolating and manipulating cancer stem cells versus human cancer cells. Dr. Sultan aims to enhance the quality of life for cancer patients through innovative research. Professor John F. Kennedy is a distinguished scientist with four degrees from The University of Birmingham. He has received prestigious awards such as the Meldola Medal for Chemistry and the Carbohydrate Chemistry Award by the Royal Society of Chemistry. Prof. Kennedy has held various professional appointments, including Director of the Birmingham Carbohydrate and Protein Technology Group and Professor of Applied Chemistry at Glyndwr University. He has published over 800 papers and authored or edited around twenty books. His research interests include carbohydrate chemistry, enzyme technology, and the environmental impact of industrial processes. Prof. Kennedy has been involved in developing innovative solutions for medical and environmental challenges, demonstrating a commitment to advancing science for the benefit of society.

納迪亞·M·哈姆迪教授自2004年以來一直是科學界的知名研究者，對科學社群做出了重要貢獻。她擁有超過120篇的出版物、5章書籍章節，以及43的Scopus h-index。她指導了50名碩士和博士生，並獲得了多項獎項，包括2025年終身成就獎、2025年奧巴達國際傑出研究者獎、2024年ASU科技科學感謝獎、2023年埃及國家科學技術研究院肖基·哈達德博士癌症獎，以及2023年2月的國際「溫迪·哈爾萬」最高榮譽獎，還有2025年和2021年的幾個國際榮譽獎。她的研究興趣包括藥物臨床生物化學、分子生物學、遺傳研究、生物標記、免疫腫瘤學、生物技術和納米生物技術。她專注於理解癌症和疾病的遺傳及表觀遺傳機制，開發疾病預後的生物標記，並探索創新的治療方法。她還是9本Q1和Q2 Scopus期刊的編輯委員會成員，以及國際和區域性資助、獎項和科學期刊的審稿人。艾哈邁德·S·蘇爾坦教授是喬治城大學醫學中心的幹細胞與分子腫瘤學傑出教授。他於1999年在大阪大學醫學院獲得MD/PhD學位，並於2005年在喬治城大學獲得公共衛生碩士學位。蘇爾坦博士的研究興趣包括臨床生物化學、分子生物學、乳腺癌和肝癌的基因治療，以及幹細胞在癌症模型中的角色。他的創新研究專注於發現轉移性癌症的新方法和治療策略，分離和操控癌症幹細胞與人類癌細胞。蘇爾坦博士旨在通過創新研究提高癌症患者的生活質量。約翰·F·甘迺迪教授是擁有四個學位的傑出科學家，來自伯明翰大學。他獲得了化學梅爾多拉獎章和皇家化學學會碳水化合物化學獎等多項榮譽。甘迺迪教授曾擔任多個專業職位，包括伯明翰碳水化合物與蛋白質技術小組主任及格林德爾大學應用化學教授。他發表了超過800篇論文，並撰寫或編輯了約20本書籍。他的研究興趣包括碳水化合物化學、酶技術以及工業過程對環境的影響。甘迺迪教授致力於為醫療和環境挑戰開發創新解決方案，展現了推進科學以造福社會的承諾。